Just hours after Haryana Health Minister Anil Vij, who was administered a dose of Covaxin last month, confirmed he has developed Coronavirus symptoms, the Union Health Ministry on Saturday clarified that Vij took only the first dose of the two-dose vaccine.
"The antibodies against the infection build up in a human being only after a specific number of days pass after the second dose of the vaccine is taken. Since, this is a two-dose vaccine. Minister in question has taken only one dose of the vaccine," the ministry said in a statement.
In the case of this vaccine, trial volunteers receive two intramuscular injections approximately 28 days apart.
Participants are randomly assigned to receive Covaxin or placebo. The trial is double-blinded, such that the investigators, the participants and the company are not aware of who is assigned to which group.
The statement from the ministry came after the 67-year-old minister tested positive two weeks after being given a shot of the vaccine, which is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research, at a hospital in Ambala as part of the third phase of the trial.
"I have been tested Corona positive. I am admitted in Civil Hospital Ambala Cantt. All those who have come in close contact to me are advised to get themselves tested for corona," Vij tweeted on Saturday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)